NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New bladder treatment trial offers hope after standard therapy fails
Disease control OngoingThis study is for people with high-risk bladder cancer that has returned after standard BCG treatment and who cannot or choose not to have their bladder removed. It compares a new experimental treatment called TAR-200, which is placed directly into the bladder, against the doctor…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New bladder cancer treatment available before full approval
Disease control APPROVED_FOR_MARKETINGThis program provides early access to TAR-200 for people with high-risk bladder cancer that hasn't spread into the muscle wall. It's for patients who have tried other treatments like BCG therapy but still have cancer, and who cannot or choose not to have their bladder surgically …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC